Cargando…
The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome
Although biologics have demonstrated to be effective in T2-high asthma patients, there is little experience with these drugs in asthma–COPD overlap (ACO). The aim of this study was to compare the effectiveness of biologics in these two conditions. We included 318 patients (24 ACO and 297 asthma) tre...
Autores principales: | Pérez de Llano, Luis, Dacal Rivas, David, Marina Malanda, Nuria, Plaza Moral, Vicente, Gullón Blanco, José Antonio, Muñoz-Esquerre, Mariana, García-Moguel, Ismael, Díaz Campos, Rocío M, Martínez-Moragón, Eva, Harbenau Mena, Alicia, Cosío, Borja G, Padilla Galo, Alicia, Cisneros Serrano, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939871/ https://www.ncbi.nlm.nih.gov/pubmed/35330786 http://dx.doi.org/10.2147/JAA.S338467 |
Ejemplares similares
-
Asthma–COPD overlap: identification and optimal treatment
por: Cosío, Borja G., et al.
Publicado: (2018) -
Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
por: Pérez de Llano, Luis A, et al.
Publicado: (2022) -
Asthma-COPD overlap is not a homogeneous disorder: further supporting data
por: Pérez-de-Llano, Luis, et al.
Publicado: (2017) -
What pulmonologists think about the asthma–COPD overlap syndrome
por: Miravitlles, Marc, et al.
Publicado: (2015) -
Mixed Th2 and non-Th2 inflammatory pattern in the asthma–COPD overlap: a network approach
por: de Llano, Luis Pérez, et al.
Publicado: (2018)